What question did this study set out to answer?

The research aims to explore how lactucopicrin can enhance autophagic activity to mitigate osteoarthritis progression.

January 24, 2026AutophagyOpen Access

Lactucopicrin promotes the autophagic degradation of MAP2K4/MKK4 by mediating CCDC50 palmitoylation to alleviate osteoarthritis progression

View Full Paper

Ask AI

Bookmark

Authors

Demonstrates that lactucopicrin enhances autophagy in a mouse model of osteoarthritis, suggesting a new treatment approach.

The research aims to explore how lactucopicrin can enhance autophagic activity to mitigate osteoarthritis progression.
Used a mouse model with destabilized medial meniscus to induce osteoarthritis.
Investigated the effects of lactucopicrin on cartilage degradation and matrix integrity.
Analyzed the role of ZDHHC4 in palmitoylation and its effect on MAP2K4/MKK4 degradation.
Lactucopicrin reduced cartilage degeneration and preserved matrix integrity in osteoarthritis.
Enhanced palmitoylation of CCDC50 facilitated selective autophagy of MAP2K4/MKK4.
Results indicate a reduced activation of MAPK/JNK signaling and decreased chondrocyte senescence.

Li et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark